Arch Therapeutics (ARTH)
OTHER OTC:ARTH

Arch Therapeutics (ARTH) Financial Statements

160 Followers

Arch Therapeutics Financial Overview

Arch Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.844; its P/E ratio is -0.32; Arch Therapeutics is scheduled to report earnings on May 14, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 31.87K$ 45.87K$ 13.29K$ 16.65K$ 6.26K
Gross Profit$ 10.31K$ 22.26K$ 13.29K$ 35.37K$ -11.37K
EBIT$ -876.74K$ -1.49M$ -1.01M$ 2.62M$ -1.28M
EBITDA$ -876.18K$ -1.49M$ -1.01M$ 2.62M$ -1.28M
Net Income Common Stockholders$ -1.47M$ -2.68M$ -1.82M$ 1.98M$ -1.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 26.43K$ 205.85K$ 86.54K$ 29.50K$ 10.62K
Total Assets$ 1.54M$ 1.82M$ 1.56M$ 1.59M$ 1.72M
Total Debt$ 0.00$ 0.00$ 690.01K$ 0.00$ 0.00
Net Debt$ -26.43K$ -205.85K$ 603.47K$ -29.50K$ -10.62K
Total Liabilities$ 4.36M$ 4.12M$ 9.58M$ 7.98M$ 7.60M
Stockholders Equity$ -10.88M$ -9.58M$ -8.02M$ -6.39M$ -5.89M
Cash Flow-
Free Cash Flow$ -700.16K$ -862.61K$ -4.43M$ -599.87K$ -650.07K
Operating Cash Flow$ -700.16K$ -862.61K$ -4.43M$ -599.87K$ -650.07K
Investing Cash Flow-----
Financing Cash Flow$ 520.74K$ 845.74K$ -532.49K$ 618.74K$ -86.26K
Currency in USD

Arch Therapeutics Earnings and Revenue History

Arch Therapeutics Debt to Assets

Arch Therapeutics Cash Flow

Arch Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis